Company Information and GEM Characteristics Company Overview China Life Group Limited (the Company) is incorporated in the Cayman Islands, with shares listed on the Stock Exchange's GEM, primarily engaging in investment holding with diversified subsidiary businesses across funeral services, cemetery sales, and biotechnology instrument sales - The Company is incorporated in the Cayman Islands, with shares listed on the Stock Exchange's GEM, primarily engaged in investment holding12 - The Group's subsidiaries have diversified businesses, including funeral services in China, Taiwan, and Hong Kong, cemetery plot sales and maintenance in Vietnam, and sales of biotechnology instruments and electronic products in Hong Kong12 GEM Listing Characteristics and Risk Disclosure The Stock Exchange's GEM market provides a listing platform for SMEs, typically involving higher investment risks and potential market volatility, with no guarantee of high liquidity - The GEM market is positioned to provide a listing platform for small and medium-sized companies, with relatively higher investment risks25 - GEM securities may be subject to significant market volatility risks and do not guarantee high liquidity25 Condensed Consolidated Financial Statements Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income For the six months ended June 30, 2025, Group revenue increased to RMB 36,039 thousand, gross profit grew by 10.4% to RMB 13,212 thousand, and the loss for the period narrowed to RMB 7,172 thousand despite an operating loss of RMB 5,182 thousand Condensed Consolidated Statement of Profit or Loss and Other Comprehensive Income (For the six months ended June 30) | Indicator | 2025 (RMB'000) | 2024 (RMB'000) | Change (%) | | :--- | :--- | :--- | :--- | | Revenue | 36,039 | 34,383 | +4.8% | | Cost of sales and services | (22,827) | (22,412) | +1.9% | | Gross profit | 13,212 | 11,971 | +10.4% | | Operating loss | (5,182) | (6,745) | -23.2% | | Loss before tax | (5,931) | (7,673) | -22.7% | | Loss for the period | (7,172) | (8,909) | -19.5% | | Loss attributable to owners of the Company | (4,803) | (8,665) | -44.6% | | Basic loss per share (RMB cents) | (0.51) | (0.96) | -46.8% | | Diluted loss per share (RMB cents) | (0.38) | (1.00) | -62.0% | Condensed Consolidated Statement of Financial Position As of June 30, 2025, the Group's non-current assets slightly increased to RMB 54,750 thousand, current assets marginally decreased to RMB 195,914 thousand, and current liabilities rose to RMB 138,888 thousand, resulting in a decrease in net current assets and total equity to RMB 99,456 thousand Condensed Consolidated Statement of Financial Position (As of June 30) | Indicator | 2025年6月30日 (RMB'000) | 2024年12月31日 (RMB'000) | Change (%) | | :--- | :--- | :--- | :--- | | Non-current assets | 54,750 | 54,248 | +0.9% | | Current assets | 195,914 | 196,378 | -0.2% | | Current liabilities | 138,888 | 133,611 | +3.9% | | Net current assets | 57,026 | 62,767 | -9.1% | | Total assets less current liabilities | 111,776 | 117,015 | -4.5% | | Non-current liabilities | 12,320 | 13,481 | -8.6% | | Net assets | 99,456 | 103,534 | -3.9% | | Total equity | 99,456 | 103,534 | -3.9% | Condensed Consolidated Statement of Changes in Equity For the six months ended June 30, 2025, equity attributable to owners of the Company decreased from RMB 123,452 thousand to RMB 119,703 thousand, primarily due to a loss of RMB 4,803 thousand and non-controlling interests' capital injection of RMB 1,481 thousand Condensed Consolidated Statement of Changes in Equity (For the six months ended June 30) | Indicator | 2025年6月30日 (RMB'000) | 2024年12月31日 (RMB'000) | | :--- | :--- | :--- | | Equity attributable to owners of the Company (beginning of period) | 123,452 | 123,718 | | Loss for the period | (4,803) | (8,665) | | Exchange differences on translation of foreign operations | 1,054 | 1,797 | | Capital injection from non-controlling interests | 1,481 | 240 | | Equity attributable to owners of the Company (end of period) | 119,703 | 122,398 | Condensed Consolidated Statement of Cash Flows For the six months ended June 30, 2025, net cash used in operating activities significantly decreased to RMB 1,989 thousand, net cash from investing activities was RMB 74 thousand, net cash used in financing activities was RMB 1,255 thousand, and period-end cash and bank balances increased to RMB 110,858 thousand Condensed Consolidated Statement of Cash Flows (For the six months ended June 30) | Indicator | 2025 (RMB'000) | 2024 (RMB'000) | Change (%) | | :--- | :--- | :--- | :--- | | Net cash used in operating activities | (1,989) | (12,145) | -83.6% | | Net cash from investing activities | 74 | 704 | -89.5% | | Net cash (used in)/from financing activities | (1,255) | 1,534 | -181.8% | | Net decrease in cash and cash equivalents | (3,170) | (9,907) | -68.0% | | Cash and cash equivalents as of June 30 | 110,858 | 118,770 | -6.7% | Notes to the Financial Statements General Information The Group primarily engages in investment holding, with diversified subsidiary businesses including funeral services in China, Taiwan, and Hong Kong, cemetery sales and maintenance in Vietnam, and sales of high-end biotechnology instruments and other
中国生命集团(08296) - 2025 - 中期业绩